Crkl is a co-activator of estrogen receptor α that enhances tumorigenic potential in cancer

Molecular Endocrinology

Volumn 25, Issue 9, 2011, Pages 1499-1512

  Padmanabhan, Renjini Ambika ^a   Nirmala, Lini ^a   Murali, Megha ^a   Laloraya, Malini ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CRK LIKE PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PROTEIN SH2; PROTEIN SH3;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PREGNANCY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UTERUS;

5' UNTRANSLATED REGIONS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; IMMUNOPRECIPITATION; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES; UTERUS;

MAMMALIA;

EID: 80052297556     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-0008     Document Type: Article

References (47)

1. Ma WG, Song H, Das SK, Paria BC, Dey SK 2003 Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci USA 100: 2963-2968.
2. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS 1997 Tissue distribution and quantitative analysis of estrogen receptor-β (ERβ) and estrogen receptor- β (ER β) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 138:4613-4621.
3. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20: 358-417.
4. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW, Smith EP 1996 Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51:159-186; discussion 186-188.
5. Grandien K, Berkenstam A, Gustafsson JA 1997 The estrogen receptor gene: promoter organization and expression. Int J Biochem Cell Biol 29: 1343-1369.
6. Klinge CM 2000 Estrogen receptor interaction with co-activators and co-repressors. Steroids 65: 227-251.
7. ten Hoeve J, Morris C, Heisterkamp N, Groffen J 1993 Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene 8: 2469-2474.
8. Birge RB, Kalodimos C, Inagaki F, Tanaka S 2009 Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal 7:13.
9. Sawasdikosol S, Ravichandran KS, Lee KK, Chang JH, Burakoff SJ 1995 Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J Biol Chem 270: 2893-2896.
10. Birge RB, Fajardo JE, Mayer BJ, Hanafusa H 1992 Tyrosinephosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crkphosphotyrosine- dependent interactions in vitro. J Biol Chem 267: 10588-10595.
11. Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, Law SF, Golemis EA, Griffin JD 1997 Differential signaling after α1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1). J Biol Chem 272: 14320-14326.
12. Uemura N, Griffin JD 1999 The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration. J Biol Chem 274: 37525-37532.
13. Fish EN, Uddin S, Korkmaz M, Majchrzak B, Druker BJ, Platanias LC 1999 Activation of a CrkL-stat5 signaling complex by type I interferons. J Biol Chem 274: 571-573.
14. Laloraya M, Davoodi-Semiromi A, Kumar GP, McDuffie M, She JX 2006 Impaired Crkl expression contributes to the defective DNA binding of Stat5b in nonobese diabetic mice. Diabetes 55: 734-741.
15. Nautiyal J, Kumar PG, Laloraya M 2004 17β-estradiol induces nuclear translocation of CrkL at the window of embryo implantation. Biochem Biophys Res Commun 318: 103-112.
16. Heery DM, Kalkhoven E, Hoare S, Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387: 733-736.
17. Heery DM, Hoare S, Hussain S, Parker MG, Sheppard H. 2001 Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem 276: 6695-6702.
18. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD 1983 Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19: 147-158.
19. Wadehra M, Mainigi M, Morales SA, Rao RG, Gordon LK, Williams CJ, Braun J 2008 Steroid hormone regulation of EMP2 expression and localization in the endometrium. Reprod Biol Endocrinol 6:15.
20. Yang JZ, O'Flatharta C, Harvey BJ, Thomas W 2008 Membrane ERα-dependent activation of PKCα in endometrial cancer cells by estradiol. Steroids 73: 1110-1122.
21. Heneweer C, Kruse LH, Kindhäuser F, Schmidt M, Jakobs KH, Denker HW, Thie M 2002 Adhesiveness of human uterine epithelial RL 95-2. cells to trophoblast: rho protein regulation. Mol Hum Reprod 8: 1014-1022.
22. Hohn HP, Linke M, Denker HW 2000 Adhesion of trophoblast to uterine epithelium as related to the state of trophoblast differentiation: in vitro studies using cell lines. Mol Reprod Dev 57: 135-145.
23. John NJ, Linke M, Denker HW 1993 Quantitation of human choriocarcinoma spheroid attachment to uterine epithelial cell monolayers. In Vitro Cell Dev Biol Anim 29A: 461-468.
24. Thie M, Denker HW 2002 In vitro studies on endometrial adhesiveness for trophoblast: cellular dynamics in uterine epithelial cells. Cells Tissues Organs 172: 237-252.
25. Hong SH, Nah HY, Lee JY, Gye MC, Kim CH, Kim MK 2004 Analysis of estrogen-regulated genes in mouse uterus using cDNA microarray and laser capture microdissection. J Endocrinol 181: 157-167.
26. Smith JJ, Richardson DA, Kopf J, Yoshida M, Hollingsworth RE, Kornbluth S 2002 Apoptotic regulation by the Crk adapter protein mediated by interactions with Wee1 and Crm1/exportin. Mol Cell Biol 22: 1412-1423.
27. Senechal K, Halpern J, Sawyers CL 1996 The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene. J Biol Chem 271: 23255-23261.
28. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG 1998 Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12: 3357-3368.
29. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG 1997 The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677-684.
30. Sauvé F, McBroom LD, Gallant J, Moraitis AN, Labrie F, Giguére V 2001 CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Mol Cell Biol 21: 343-353.
31. Chen M, Ni J, Zhang Y, Muyan M, Yeh S 2008 ERAP75 functions as a coactivator to enhance estrogen receptor α transactivation in prostate stromal cells. Prostate 68: 1273-1282.
32. Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK 2002 A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm. Nature 418: 654-657.
33. Singh RR, Kaluarachchi K, Chen M, Rayala SK, Balasenthil S, Ma J, Kumar R 2006 Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s. J Biol Chem 281: 25612-25621.
34. Chang C, Norris JD, Grøn H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP 1999 Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors α and α. Mol Cell Biol 19: 8226-8239.
35. Gaillard S, Dwyer MA, McDonnell DP 2007 Definition of the molecular basis for estrogen receptor-related receptor-α-cofactor interactions. Mol Endocrinol 21: 62-76.
36. Kawajiri K, Ikuta T, Suzuki T, Kusaka M, Muramatsu M, Fujieda K, Tachibana M, Morohashi K 2003 Role of the LXXLL-motif and activation function 2 domain in subcellular localization of Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1). Mol Endocrinol 17:994-1004.
37. Ikuta T, Watanabe J, Kawajiri K 2002 Characterization of the LxxLL motif in the aryl hydrocarbon receptor: effects on subcellular localization and transcriptional activity. J Biochem 131: 79-85.
38. Litterst CM, Pfitzner E 2002 An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1. J Biol Chem 277: 36052-36060.
39. Muralidharan V, Dutta K, Cho J, Vila-Perello M, Raleigh DP, Cowburn D, Muir TW 2006 Solution structure and folding characteristics of the C-terminal SH3 domain of c-Crk-II. Biochemistry 45: 8874-8884.
40. Ogawa S, Toyoshima H, Kozutsumi H, Hagiwara K, Sakai R, Tanaka T, Hirano N, Mano H, Yazaki Y, Hirai H 1994 The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells. Oncogene 9: 1669-1678.
41. Waksman G, Kumaran S, Lubman O 2004 SH2 domains: role, structure and implications for molecular medicine. Expert Rev Mol Med 6: 1-18.
42. Kohler MF, Berkholz A, Risinger JI, Elbendary A, Boyd J, Berchuck A 1995 Mutational analysis of the estrogen-receptor gene in endometrial carcinoma. Obstet Gynecol 86: 33-37.
43. Zhang QX, Borg A, Wolf DM, Oesterreich S, Fuqua SA 1997 An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res 57: 1244-1249.
44. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
45. Saxena D, Purohit SB, Kumer GP, Laloraya M 2000 Increased appearance of inducible nitric oxide synthase in the uterus and embryo at implantation. Nitric Oxide 4: 384-391.
46. Guichet A, Copeland JW, Erdélyi M, Hlousek D, Závorszky P, Ho J, Brown S, Percival-Smith A, Krause HM, Ephrussi A 1997 The nuclear receptor homologue Ftz-F1 and the homeodomain protein Ftz are mutually dependent cofactors. Nature 385: 548-552.
47. Schwartz CJ, Sampson HM, Hlousek D, Percival-Smith A, Copeland JW, Simmonds AJ, Krause HM 2001 FTZ-factor1 and fushi tarazu interact via conserved nuclear receptor and coactivator motifs. EMBO J 20: 510-519.